Kevin Lynch, key account manager, life sciences, Schneider Electric explains how the sector can leverage digital technologies to streamline the technology learning curve.
Zymewire has released its highly anticipated 2024 Biopharma Recap Report, offering data-driven insights into global biopharma funding, clinical trial activity, and biotech company formation over the prior year, based on data from biopharma companies.
Johnson & Johnson has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended expanding the Marketing Authorisation for TREMFYA (guselkumab).
medac Group has announced the commissioning of its latest investment: the third production line at oncomed, a production site in the Czech Republic operated by medac.
H&T Presspart (a division of the Heitkamp & Thumann Group) has announced the launch of Vytal, a ready-to-use (RTU) snap-fit closure solution for advanced therapeutics.
Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in pharmaceutical products in the EU-27. This is outlined in a report prepared by Logista Freight, Logista's long-haul, full-load transport subsidiary.
Verista, a provider of automation, compliance, and quality solutions for the pharmaceutical industry, is excited to announce its participation at INTERPHEX 2025, on 1-3rd April at the Jacob Javits Center in New York City, NY, at booth 2860.
As a specialist in scalable, secure corporate payment solutions, B4B Payments continues to enhance its support for the pharmaceutical sector, offering innovative, compliance-friendly solutions to streamline operations and improve financial processes.
